Baird Initiates Coverage on Several Medical Instruments & Supplies Stocks
Baird initiates coverage on Boston Scientific (NYSE: BSX) with an Outperform rating and a $13 price target.
Baird initiates coverage on the following companies with a 'Neutral' rating: C.R. Bard (NYSE: BCR) PT $79; Edwards Lifesciences (NYSE: EW) PT $64; Medtronic (NYSE: MDT) PT $34; and St. Jude (NYSE: STJ) PT $40.
Related Categories
New CoverageStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
